Adva Kubi
Impact in
- Oncology top 2%
- CAR-T cell therapy research
- Cancer Immunotherapy and Biomarkers
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
- Oncology 11
- CAR-T cell therapy research 9
- Peptidase Inhibition and Analysis 2
-
- Immunotherapy and Immune Responses 3
- T-cell and B-cell Immunology 2
- Co-authors
- Michal J. Besser (13 shared papers)Orit Itzhaki (11 shared papers)Jacob Schachter (11 shared papers)Gal Markel (10 shared papers)Ronnie Shapira‐Frommer (8 shared papers)Avraham J. Treves (6 shared papers)Bruria Shalmon (5 shared papers)Arnon Nagler (6 shared papers)
- Journals
- Clinical Cancer Research (2 papers)Journal of Immunotherapy (2 papers)Journal for ImmunoTherapy of Cancer (1 paper)Frontiers in Oncology (1 paper)Molecular Carcinogenesis (1 paper)
- Partner nations
- IsraelUnited StatesAustralia
In The Last Decade
Adva Kubi
13 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 45
- Oncology 970
- Immunology 638
- Genetics 215
- Immunology and Allergy 27
- Cancer Research 62
Countries citing papers authored by Adva Kubi
This map shows the geographic impact of Adva Kubi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adva Kubi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adva Kubi more than expected).
Fields of papers citing papers by Adva Kubi
This network shows the impact of papers produced by Adva Kubi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adva Kubi. The network helps show where Adva Kubi may publish in the future.
Co-authors
The 25 scholars most cited alongside Adva Kubi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 357 | |
| 2 | 2013 | 298 | |
| 3 | 2011 | 126 | |
| 4 | 2009 | 97 | |
| 5 | 2018 | 92 | |
| 6 | 2009 | 53 | |
| 7 | 2013 | 48 | |
| 8 | 2020 | 39 | |
| 9 | 2013 | 39 | |
| 10 | 2022 | 26 | |
| 11 | 2020 | 23 | |
| 12 | 2015 | 13 | |
| 13 | 2009 | 12 |
About Adva Kubi
Adva Kubi is a scholar working on Oncology, Immunology, Immunology and Allergy, Molecular Biology and Electrical and Electronic Engineering, having authored 13 papers that have together received 1.2k indexed citations. Recurring topics across this work include CAR-T cell therapy research (9 papers), Immunotherapy and Immune Responses (3 papers), Cell Adhesion Molecules Research (3 papers), T-cell and B-cell Immunology (2 papers), Peptidase Inhibition and Analysis (2 papers), Angiogenesis and VEGF in Cancer (1 paper), Silicon Carbide Semiconductor Technologies (1 paper) and Multiple Myeloma Research and Treatments (1 paper). The work is most often cited by research in Oncology (970 citations), Immunology (638 citations), Genetics (215 citations), Immunology and Allergy (27 citations) and Cancer Research (62 citations). Adva Kubi has collaborated with scholars based in Israel, United States and Australia. Frequent co-authors include Michal J. Besser, Orit Itzhaki, Jacob Schachter, Gal Markel, Ronnie Shapira‐Frommer, Avraham J. Treves, Bruria Shalmon, Arnon Nagler, Daphna Levy and Avichai Shimoni. Their work appears in journals such as Clinical Cancer Research, Journal of Immunotherapy, Journal for ImmunoTherapy of Cancer, Frontiers in Oncology and Molecular Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.